Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

Rheumatology (United Kingdom)

Volumn 53, Issue 5, 2014, Pages 882-889

  Herlyn, Karen ^a,b   Buckert, Frederike ^a,b   Gross, Wolfgang L ^a,b   Reinhold keller, Eva ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Klinikum Bad Bramstedt   (Germany)

Author keywords

ANCA associated vasculitis; Epidemiology; Giant cell arteritis; Granulomatosis with polyangiitis; Prevalence

Indexed keywords

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CHILD; CHURG STRAUSS SYNDROME; DISEASE CLASSIFICATION; FEMALE; GERMANY; GIANT CELL ARTERITIS; GRANULOMATOSIS; GRANULOMATOSIS WITH POLYANGIITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RURAL POPULATION; SEX DIFFERENCE; URBAN POPULATION; VERY ELDERLY;

ANCA-ASSOCIATED VASCULITIS; EPIDEMIOLOGY; GIANT CELL ARTERITIS; GRANULOMATOSIS WITH POLYANGIITIS; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CHILD; CHURG-STRAUSS SYNDROME; FEMALE; GERMANY; GIANT CELL ARTERITIS; HUMANS; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RURAL POPULATION; YOUNG ADULT;

EID: 84898808242     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket440     Document Type: Article

References (32)

1. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000; 43:2481-7.
2. Knight A, Ekbom A, Brandt L et al. Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001. J Rheumatol 2006;33:2060-3.
3. Watts RA, Gonzalez-Gay MA, Lane SE et al. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 2001;60:170-2.
4. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 2005;53:93-9.
5. Cotch MF, Hoffman GS, Yerg DE et al. The epidemiology of Wegener's granulomatosis. Arthritis Rheum 1996;39: 87-92.
6. Takala JH, Kautiaienen H, Malmberg H et al. Incidence of Wegener's granulomatosis in Finland 1981-2000. Clin Exp Rheumatol 2008;26(Suppl 49):S81-5.
7. Herlyn K, Hellmich B, Gross WL et al. Stabile Inzidenz systemischer Vaskulitiden in Schleswig-Holstein. Dtsch Arztebl 2008;105:355-61.
8. Watts R, Mooney J, MacGregor A et al. Epidemiology of ANCA-associated vasculitis in the UK-a 20-year study. ACR/ARHP Scientific Meeting, San Francisco, CA, 2008, Poster 1858.
9. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J et al. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference Definitions. Arthritis Rheum 2003; 49:388-93.
10. Abdul-Rahman AM, Molteno AC, Bevin TH. The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis. N Z Med J 2011;124:44-52.
11. Fujimoto S, Uezono S, Hisanaga S et al. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol 2006; 1:1016-22.
12. Gatenby PA, Lucas RM, Engelsen O et al. Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 2009;61:1417-24.
13. Mahr A, Guillevin L, Poissonnet M et al. Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome in a French urban multi-ethnic population in 2000: a capture-recapture estimate. Arthritis Care Res 2004;51:92-9.
14. Mohammad AJ, Jacobsson LTH, Mahr AD et al. Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology 2007;46:1329-37.
15. Reinhold-Keller E, Zeidler A, Gutfleisch J et al. Giant cell arteritis is more prevalent in urban than in rural population: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology 2000;39: 1396-402.
16. Watts RA, Al-Taiar A, Scott DGI et al. Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database. Arthritis Care Res 2009;61: 1412-6.
17. Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66:222-7.
18. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
19. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-17.
20. Fries JF, Hunder GG, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 1990;33:1135-6.
21. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg- Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
22. Ormerod AS, Cook MC. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and southeastern New South Wales. Intern Med J 2008;38:816-23.
23. Stratta P, Marcuccio C, Campo A et al. Improvement in relative survival of patients with vasculitis: study of 101 cases compared the general population. Int J Immunopathol Pharmacol 2008;21:631-42.
24. Holle JU, Gross WL, Latza U et al. Improved outcome of 445 Wegener's granulomatosis patients in a German vasculitis center over four decades. Arthritis Rheum 2011; 63:257-66.
25. Eriksson P, Jacobsson L, Lindell A et al. Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts. J Intern Med 2009;265:496-506.
26. Arning L, Holle JU, Harper L et al. Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis? Ann Rheum Dis 2011;70:707-8.
27. Gibson A, Stamp LK, Chapman PT et al. The epidemiology of Wegener's granulomatosis and microscopic polyangiitis in a southern hemisphere region. Rheumatology 2006;45: 624-8.
28. Huston KA, Hunder GG, Lie JT et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 1978;88:162-7.
29. Machado EB, Michet CJ, Ballard DJ et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
30. Kermani TA, Schafer VS, Crowson CS et al. Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 2010;69:780-1.
31. Duna GF, Cotch MF, Galperin C et al. Wegener's granulomatosis: role of environmental exposures. Clin Exp Rheumatol 1998;16:669-74.
32. Knight A, Sandin S, Askling J. Occupational risk factors for Wegener's granulomatosis: a case-control study. Ann Rheum Dis 2010;69:737-40.